Seminar room, ZLF, 2nd floor
Organizer:
BBC committee
"Identification of mechanisms of resistance to Fulvestrant plus Ribociclib in ER+/HER2-advanced breast cancer“
"Immunecheckpoint Blockade in Breast Cancer – Current and Future standard of Care"
"Imlunestrant, an oral selective estrogen receptor degrader, in estrogen receptor-positive advanced breast cancer"
Export event as iCal
Social Media